Login / Signup

Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer.

Shahrokh F ShariatTakahiro KimuraKenichi HataShintaro NaritaShingo HatakeyamaYuki EneiMahito AtsutaKeiichiro MoriKoki ObayashiKentaro YoshiharaYosuke KondoTakahiro OguchiIbuki SadakaneTomonori HabuchiChikara OhyamaShahrokh F ShariatShin Egawa
Published in: The Prostate (2022)
Castration status did not affect the risk of severe neutropenia or FN in mPCa patients treated with docetaxel regardless of the disease state. Failure to provide primary prophylaxis and advanced patient age are independent risk factors of severe neutropenia; while patients with poor PS are more likely to develop FN. These findings may help guide the clinical decision-making for proper candidate selection of docetaxel treatment.
Keyphrases
  • prostate cancer
  • locally advanced
  • risk factors
  • decision making
  • squamous cell carcinoma
  • early onset
  • small cell lung cancer
  • radical prostatectomy
  • case report
  • combination therapy